LCM
AMLX icon

Landscape Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

Landscape Capital Management’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$170K Hold
12,226
– – 0.01% 647
2025
Q4 		$148K Buy
12,226
+1,825
+18% +$24.8K 0.01% 639
2025
Q3 		$141K Buy
+10,401
New +$97.9K 0.01% 570
2025
Q1 		– Sell
-49,661
Closed -$188K – 628
2024
Q4 		$188K Buy
+49,661
New +$234K 0.02% 599
2024
Q1 		– Sell
-33,689
Closed -$496K – 734
2023
Q4 		$496K Buy
+33,689
New +$516K 0.04% 409

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Landscape Capital Management's AMLX Position: Q1 2026 in Review

Landscape Capital Management held its Amylyx Pharmaceuticals (AMLX) position steady in Q1 2026 at 12,226 shares worth $170K. The position accounts for 0.01% of the portfolio, ranked #647.

Landscape Capital Management first reported a position in AMLX in Q4 2023 and has held it in 5 quarters since. The position peaked at $496K in Q4 2023. 171 funds tracked by Wall St. Rank hold AMLX as of Q1 2026.

  • Landscape Capital Management held 12,226 shares of Amylyx Pharmaceuticals worth $170K as of Q1 2026.
  • Landscape Capital Management left its Amylyx Pharmaceuticals share count unchanged in Q1 2026.
  • Amylyx Pharmaceuticals made up 0.01% of Landscape Capital Management's portfolio in Q1 2026, its #647 holding.
  • Landscape Capital Management first reported a position in Amylyx Pharmaceuticals in Q4 2023 and has held it in 5 quarters since.
  • Landscape Capital Management's Amylyx Pharmaceuticals position peaked at $496K in Q4 2023.
  • 171 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q1 2026.

Based on Landscape Capital Management's 13F filing for Q1 2026, filed 12 May 2026.